首页|儿童孤独症谱系障碍的药物治疗现状与研究进展

儿童孤独症谱系障碍的药物治疗现状与研究进展

扫码查看
孤独症谱系障碍(autism spectrum disorder,ASD)是以社交障碍和受限的重复刻板行为为基本特征的神经发育障碍.ASD发病机制尚不明确,目前没有公认的药物可用于改善ASD核心症状.药物治疗主要针对其情绪问题和不当行为,以利培酮、阿立哌唑为代表的非典型二代抗精神病药是处理ASD儿童情绪行为问题的常用药物.注意缺陷多动障碍、癫痫、胃肠道症状与睡眠障碍等共患病在ASD儿童中常见,哌甲酯、托莫西汀是治疗ASD共患注意缺陷多动障碍的首选药物.目前仍有一些药物尚未广泛应用于临床,需要有更多循证医学证据支持.
Current status and research progress of drug therapy in childhood autism spectrum disorder
Autism spectrum disorder(ASD)is a neurodevelopmental disorder characterized by social disorders and restricted,repetitive stereotyped behaviors.The pathogenesis of ASD is not clear.There are no recognized drugs that could be used to improve the core symptoms of ASD.Drug treatment is mainly aimed at their emotional problems and inappropriate behavior.Atypical second-generation antipsychotic drugs such as risperidone and aripiprazole are commonly used to deal with the emotional and behavioral problems of children with ASD.Comorbidities such as attention deficit hyperactivity disorder,epilepsy,gastrointestinal symptoms and sleep disorder are common in children with ASD.Methylphenidate and atomoxetine are the first choice for the treatment of ASD with attention deficit hyperactivity disorder.At present,there are still some drugs that have not been widely used in clinical practice,and need further support from evidence-based medicine.

Autism spectrum disorderComorbiditiesDrug therapyChild

王泽鹏、宋超、邵宁、竺智伟、吴玲玲

展开 >

国家儿童健康与疾病临床医学研究中心 浙江大学医学院附属儿童医院发育行为儿科,杭州 310052

孤独症谱系障碍 共患病 药物治疗 儿童

浙江省自然科学基金

LTGY24H090005

2024

国际儿科学杂志
中华医学会,中国医科大学

国际儿科学杂志

CSTPCD
影响因子:1.057
ISSN:1673-4408
年,卷(期):2024.51(4)